Comorbidity of fear of progression and anxiety disorders in cancer patients

General Hospital Psychiatry

Volumn 36, Issue 6, 2014, Pages 613-619

  Dinkel, Andreas ^a   Kremsreiter, Katrin ^a   Marten Mittag, Birgitt ^a   Lahmann, Claas ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anxiety disorders; Fear of progression; Fear of recurrence; Illness related fears; Psycho oncology

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; CANCER PATIENT; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEAR; FEAR OF PROGRESSION; FEAR OF PROGRESSION QUESTIONNAIRE; FEMALE; HUMAN; HYPOCHONDRIASIS; MAJOR CLINICAL STUDY; MALE; PATIENT HEALTH QUESTIONNAIRE; QUESTIONNAIRE; STATE WORRY QUESTIONNAIRE; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; WORRY DOMAINS QUESTIONNAIRE; AGED; ANXIETY DISORDERS; DISEASE COURSE; MIDDLE AGED; NEOPLASM; PSYCHOLOGY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEAR; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; YOUNG ADULT;

EID: 84919428321     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2014.08.006     Document Type: Article

References (54)

1. Hoyer J., Eifert G.H., Einsle F., Zimmermann K., Krauss S., Knaut M., et al. Heart-focused anxiety before and after cardiac surgery. J Psychosom Res 2008, 64:291-297.
2. Pedersen S.S., Theuns D.A.M.J., Jordaens L., Kupper N. Course of anxiety and device-related concerns in implantable cardioverter defibrillator patients the first year post implantation. Europace 2010, 12:1119-1126.
3. Stjernman H., Tysk C., Almer S., Ström M., Hjortswang H. Worries and concerns in a large unselected cohort of patients with Crohn's disease. Scand J Gastroenterol 2010, 45:696-706.
4. Wild D., von Maltzahn R., Brohan E., Christensen T., Clauson P., Gonder-Frederick L. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ Couns 2007, 68:10-15.
5. Dankert A., Duran G., Engst-Hastreiter U., Keller M., Waadt S., Henrich G., et al. Progredienzangst bei Patienten mit Tumorerkrankungen, Diabetes mellitus und entzündlich-rheumatischen Erkrankungen [Fear of progression in patients with cancer, diabetes mellitus and chronic arthritis]. Rehabilitation 2003, 42:155-163.
6. Herschbach P., Berg P., Dankert A., Duran G., Engst-Hastreiter U., Waadt S., et al. Fear of progression in chronic diseases. Psychometric properties of the Fear of Progression Questionnaire (FoP-Q). J Psychosom Res 2005, 58:505-511.
7. Herschbach P., Dinkel A. Fear of progression. Psycho-Oncology (Recent Results in Cancer Research 197) 2014, 11-29. Springer, Berlin. U. Goerling (Ed.).
8. Berg P., Book K., Dinkel A., Henrich G., Marten-Mittag B., Mertens D., et al. Progredienzangst bei chronischen Erkrankungen [Fear of progression in chronic diseases]. Psychother Psych Med 2011, 61:32-37.
9. Kwakkenbos L., van Lankveld W.G.J.M., Vonk M.C., Becker E.S., van den Hoogen F.H.J., van den Ende C.H.M. Disease-related and psychosocial factors associated with depressive symptoms in patients with systemic sclerosis, including fear of progression and appearance self-esteem. J Psychosom Res 2012, 72:199-204.
10. Kühl K., Kuhn C., Kenn K., Rief W. Der COPD-Angst-Fragebogen (CAF): Ein neues Instrument zur Erfassung krankheitsspezifischer Ängste bei COPD-Patienten [The COPD-Anxiety-Questionnaire (CAF): a new instrument to assess illness specific anxiety in COPD patients]. Psychother Psych Med 2011, 61:e1-e9.
11. Keil D.C., Stenzel N.M., Kühl K., Vaske I., Mewes R., Rief W., et al. The impact of chronic obstructive pulmonary disease-related fears on disease-specific disability. Chron Respir Dis 2014, 11:31-40.
12. Muschalla B., Glatz J., Linden M. Heart-related anxieties in relation to general anxiety and severity of illness in cardiology patients. Psychol Health Med 2014, 19:83-92.
13. Shim E.J., Shin Y.W., Oh D.Y., Hahm B.J. Increased fear of progression in cancer patients with recurrence. Gen Hosp Psychiatry 2010, 32:169-175.
14. Mehnert A., Berg P., Henrich G., Herschbach P. Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psychooncology 2009, 18:1273-1280.
15. Erim Y., Loquai C., Schultheis U., Lindner M., Beckmann M., Schadendorf C., et al. Anxiety, posttraumatic stress, and fear of cancer progression in patients with melanoma in cancer aftercare. Onkologie 2013, 36:540-544.
16. Thewes B., Butow P., Bell J.L., Beith J., Stuart-Harris R., Grossi M., et al. Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviors. Support Care Cancer 2012, 20:2651-2659.
17. Simard S., Thewes B., Humphris G., Dixon M., Hayden C., Mireskandari S., et al. Fear of cancer recurrence in adult cancer survivors: a systematic review. J Cancer Surviv 2013, 7:300-322.
18. Lee-Jones C., Humphris G., Dixon R., Hatcher M.B. Fear of cancer recurrence - a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology 1997, 6:95-105.
19. Custers J.A.E., van den Berg S.W., van Laarhoven H.W.M., Bleiker E.M.A., Gielissen M.F.M., Prins J.B. The Cancer Worry Scale. Detecting fear of recurrence in breast cancer survivors. Cancer Nurs 2014, 37:E44-E50.
20. Koch L., Jansen L., Brenner H., Arndt V. Fear of recurrence and disease progression in long-term (≥5years) cancer survivors - a systematic review of quantitative studies. Psychooncology 2013, 22:1-11.
21. Thewes B., Butow P., Zachariae R., Christensen S., Simard S., Gotay C. Fear of cancer recurrence: a systematic literature review of self-report measures. Psychooncology 2012, 21:571-587.
22. Herschbach P., Keller M., Knight L., Brandl T., Huber B., Henrich G., et al. Psychological problems of cancer patients: a cancer distress screening with a cancer-specific questionnaire. Br J Cancer 2004, 91:504-511.
23. Armes J., Crowe M., Colbourne L., Morgan H., Murrells T., Oakley C., et al. Patients' supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol 2009, 27:6172-6179.
24. Harrison J.D., Young J.M., Price M.A., Butow P., Solomon M.J. What are the unmet supportive care needs of people with cancer?. Support Care Cancer 2009, 17:1117-1128.
25. Salander P. Motives that cancer patients in oncological care have for consulting a psychologist - an empirical study. Psychooncology 2010, 19:248-254.
26. Gurevich M., Devins G.M., Rodin G.M. Stress response syndromes and cancer: conceptual and assessment issues. Psychosomatics 2002, 43:259-281.
27. Wittchen H.U., Zaudig M., Fydrich T. Strukturiertes Klinisches Interview für DSM-IV [Structured Clinical Interview for DSM-IV, German version] 1997, Hogrefe, Göttingen.
28. Karnofsky D.A., Burchenal J.H. The clinical evaluation of chemotherapeutic agents in cancer. Evaluation of chemotherapeutic agents 1949, 191-205. Columbia University Press, New York, NY. C.M. MacLeod (Ed.).
29. Starcevic V. Hypochondriasis and health anxiety: conceptual challenges. Br J Psychiatry 2013, 202:7-8.
30. Noyes R. The relationship of hypochondriasis to anxiety disorders. Gen Hosp Psychiatry 1999, 21:8-17.
31. Meyer T.J., Miller M.L., Metzger R.L., Borkovec T.D. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther 1990, 28:487-495.
32. Stöber J. Besorgnis: Ein Vergleich dreier Inventare zur Erfassung allgemeiner Sorgen [Worry: a comparison of three questionnaires for the measurement of general worries]. Z Diff Diagn Psychol 1995, 16:50-63.
33. Tallis F., Eysenck M.W., Mathews A. A questionnaire for the measurement of non-pathological worry. Pers Indiv Diff 1992, 13:161-168.
34. Löwe B., Wahl I., Rose M., Spitzer C., Glaesmer H., Wingenfeld K., et al. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord 2010, 122:86-95.
35. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002, 64:258-266.
36. Kocalevent R.D., Hinz A., Brähler E. Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population. BMC Psychiatry 2013, 13:91.
37. Singer S., Bringmann H., Hauss J., Kortmann R.D., Köhler U., Krauß O., et al. Häufigkeit psychischer Begleiterkrankungen und der Wunsch nach psychosozialer Unterstützung bei Tumorpatienten im Akutkrankenhaus [Prevalence of concomitant psychiatric disorders and the desire for psychosocial help in patients with malignant tumors in an acute hospital]. Dtsch Med Wochenschr 2007, 132:2071-2076.
38. Bardwell W.A., Natarajan L., Dimsdale J.E., Rock C.L., Mortimer J.E., Hollenbach K., et al. Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. J Clin Oncol 2006, 24:2420-2427.
39. Siedentopf F., Marten-Mittag B., Utz-Billing I., Schoenegg W., Kentenich H., Dinkel A. Experiences with a specific screening instrument to identify psychosocial support needs in breast cancer patients. Eur J Obstet Gynecol Reprod Biol 2010, 148:166-171.
40. Harrison J., Maguire P., Ibbotson T., Macleod R., Hopwood P. Concerns, confiding and psychiatric disorder in newly diagnosed cancer patients: a descriptive study. Psychooncology 1994, 3:173-179.
41. Stark D., Kiely M., Smith A., Velikova G., House A., Selby P. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol 2002, 20:3137-3148.
42. Parle M., Jones B., Maguire P. Maladaptive coping and affective disorders among cancer patients. Psychol Med 1996, 26:735-744.
43. Skaali T., Fosså S.D., Bremnes R., Dahl O., Haaland C.F., Hauge E.R., et al. Fear of recurrence in long-term testicular cancer survivors. Psychooncology 2009, 18:580-588.
44. Singer S., Das-Munshi J., Brähler E. Prevalence of mental health conditions in cancer patients in acute care - a meta-analysis. Ann Oncol 2010, 21:925-930.
45. Mitchell A.J., Chan M., Bhatti H., Halton M., Grassi L., Johansen C., et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011, 12:160-174.
46. Vehling S., Koch U., Ladehoff N., Schön G., Wegscheider K., Heckl U., et al. Prävalenz affektiver und Angststörungen bei Krebs: systematischer Literaturreview und Metaanalyse [Prevalence of affective and anxiety disorders in cancer: systematic literature review and meta-analysis]. Psychother Psych Med 2012, 62:249-258.
47. Greer J.A., Solis J.M., Temel J.S., Lennes I.T., Prigerson H.G., Maciejewski P.K., et al. Anxiety disorders in long-term survivors of adult cancers. Psychosomatics 2011, 52:417-423.
48. Roth A., Nelson C.J., Rosenfeld B., Warshowski A., O'Shea N., Scher H., et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics 2006, 47:340-347.
49. Thewes B., Bell M.L., Butow P., Beith J., Boyle F., Friedlander M., et al. Psychological morbidity and stress but not social factors influence level of fear of cancer recurrence in young women with early breast cancer: results of a cross-sectional study. Psychooncology 2013, 22:2797-2806.
50. Mehnert A., Koch U., Sundermann C., Dinkel A. Predictors of fear of recurrence in patients one year after cancer rehabilitation: a prospective study. Acta Oncol 2013, 52:1102-1109.
51. Thewes B., Brebach R., Dzidowska M., Rhodes P., Sharpe L., Butow P. Current approaches to managing fear of cancer recurrence: a descriptive survey of psychosocial and clinical health professionals. Psychooncology 2014, 23:390-396.
52. Herschbach P., Berg P., Waadt S., Duran G., Engst-Hastreiter U., Henrich G., et al. Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer. Psychother Psychosom 2010, 79:31-38.
53. Herschbach P., Book K., Dinkel A., Berg P., Waadt S., Duran G., et al. Evaluation of two group therapies to reduce fear of progression in cancer patients. Support Care Cancer 2010, 18:471-479.
54. Dinkel A., Herschbach P., Berg P., Waadt S., Duran G., Engst-Hastreiter U., et al. Determinants of long-term response to group therapy for dysfunctional fear of progression in chronic diseases. Behav Med 2012, 38:1-5.